|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Mar 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Financing Receivable, Excluding Accrued Interest, Credit Loss Expense (Reversal) | |||||
| Provision for credit losses | |||||
| Stock based compensation expense | |||||
| Depreciation and amortization expense | |||||
| Loss (gain) on sale of loans, net | |||||
| Bank Owned Life Insurance Income | |||||
| Amortization and accretion of loan premiums and discounts and deferred charges | |||||
| Amortization and accretion of premiums and discounts - securities | |||||
| Decrease (increase) in accrued interest receivable | |||||
| Increase (Decrease) in Other Assets | |||||
| Increase (Decrease) in Other Liabilities | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Proceeds from sales of investments: Available-for-sale | |||||
| Proceeds from principal payments, maturities and calls of investments: Available-for-sale | |||||
| Proceeds from principal payments, maturities and calls of investments: Held-to-maturity | |||||
| Purchase of bank-owned life insurance | |||||
| Proceeds from bank owned life insurance | |||||
| Loans held-for-investment, net of originations and repayments/payoffs and maturities | |||||
| Payments to Acquire Other Investments | |||||
| Loans purchased from third parties | |||||
| Proceeds from participation loans sold | |||||
| Proceeds from sale of loans | |||||
| Redemption of FHLB-NY stock | |||||
| Purchase of premises and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Net increase in deposits | |||||
| Proceeds from short-term borrowings | |||||
| Repayments of Short-Term Debt | |||||
| Proceeds from Issuance of Long-term Debt | |||||
| Repayments of Long-Term Debt | |||||
| Proceeds from Issuance of Common Stock | |||||
| Proceeds from Issuance of Preferred Stock | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, and cash equivalents - Beginning Balance | |||||
| Cash and cash equivalents - Ending Balance | |||||
| Supplemental cash flow information: | |||||
| Noncash financing and investing activities | |||||
| Recognition of right-of-use asset | |||||
| Operating Lease, Liability | |||||
| Recognition of finance lease asset | |||||
| Conversion of preferred stock to commom stock | |||||
| Cash paid for: | |||||
| Interest | |||||
| Income taxes | |||||
Loading...